series-c-plus
Stage
2016
Founded
4
Investors
About
Kymera Therapeutics is a biotechnology company focused on discovering and developing targeted protein degradation therapies to treat serious diseases.
Explore Kymera Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.